As of November 2024, Shin Nippon Biomedical Laboratories has a market cap of $340.57M. This makes Shin Nippon Biomedical Laboratories the world's 13870th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $469.56M | -5.24% |
2023 | $495.54M | -24.87% |
2022 | $659.55M | 59.15% |
2021 | $414.41M | 110.37% |
2020 | $196.99M | 6.97% |
2019 | $184.15M | -5.82% |
2018 | $195.53M | 15.72% |
2017 | $168.97M | -1.19% |
2016 | $171.02M | 41.20% |
2015 | $121.11M | -47.53% |
2014 | $230.84M | -40.75% |
2013 | $389.60M | 326.52% |
2012 | $91.34M | 59.69% |
2011 | $57.20M | -49.22% |
2010 | $112.65M | -29.82% |
2009 | $160.51M | -22.32% |
2008 | $206.62M | -58.43% |
2007 | $497.00M | -20.61% |
2006 | $625.99M | 9.94% |
2005 | $569.37M | 390.82% |
2004 | $116.00M | - |